Uso de fármacos biológicos en dermatosis fuera de la...

Uso de fármacos biológicos en dermatosis fuera de la indicación aprobada. Segunda parte: etanercept, efalizumab, alefacept, rituximab, daclizumab, basiliximab, omalizumab y cetuximab

G. Guhl, B. Díaz-Ley, J. Fernández-Herrera
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
99
Year:
2008
DOI:
10.1016/s0001-7310(08)74612-x
File:
PDF, 2.49 MB
2008
Conversion to is in progress
Conversion to is failed